molecular-design
(6)
James Summerton's very small change of plan
James E. Summerton founded the company that became Sarepta Therapeutics. His longer story runs through molecular models, a New Year's Day invention, and an Oregon business built to put that invention in other people's hands.
Joshua Meier Waited for the Machines to Learn Biology
He studied biology as a teenager, helped teach AI the language of proteins, and waited until 2024 to start Chai Discovery. Now Joshua Meier has to turn a research bet into a dependable tool for scientists.
Jack Dent and the Idea That Had to Wait
A 99-cent app maker became Stripe’s youngest staff engineer. Years after a Harvard friendship and an early nudge from Sam Altman, Jack Dent returned to an unfinished idea and helped turn Chai Discovery into a working platform for molecular design.
The Twenty-Well Bet Behind Chai Discovery
Chai Discovery wants scientists to order up an antibody with the precision of an engineering drawing. Its first persuasive exhibit was a remarkably small experiment: no more than 20 designs for each target.
Albert Invent
Albert Invent builds an AI-native operating system for chemists and materials scientists, unifying electronic lab notebooks, LIMS, regulatory compliance and predictive AI into one cloud platform that aims to compress decades-long R&D cycles into weeks.
Nick Talken
Nick Talken is the Co-Founder and CEO of Albert Invent, an Oakland-based AI platform that is transforming how chemists and materials scientists do research and development. A chemical engineer by training who learned to code, Talken spent years inside Henkel's global R&D organization before spinning out Albert Invent in 2022 with a team of co-founders who built the product from within. The company's platform - used by over 3,000 scientists across 142+ labs in 30+ countries at companies like Kenvue, Henkel, and Chemours - has raised over $52 million from top-tier investors including Coatue, Index Ventures, TCV, and J.P. Morgan Private Capital.